Pursuant to Regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, ANG Lifesciences India has informed that the meeting of Board of Directors of the Company is scheduled to be held on Thursday, November 14, 2019 at 4:00 PM at the Registered Office of the Company situated at Darbara Complex, SCO-113, District Shopping Centre, B Block, Ranjit Avenue, Amritsar, 143001, to Consider and Approve the Un-Audited Financial Results of the Company for the half year ended September 30, 2019. Further, pursuant to its intimation dated October 01, 2019, the trading window of the company shall remain closed until November 16, 2019 for the aforesaid purpose.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: